Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 25, 2023
Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched studyYongjian Guo, Jingqiang Wu, Licong Liang, et al.
BMC Cancer|February 5, 2025
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trialXiaoyang Hong, Yongjian Guo, Wenbo Shi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 20, 2023
Regorafenib enhances anti-tumor efficacy of immune checkpoint inhibitor by regulating IFN-γ/NSDHL/SREBP1/TGF-β1 axis in hepatocellular carcinomaLulu Xie, Mingyu Liu, Mingyue Cai, et al.
Cell Death & Disease|January 13, 2023
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastasesMingyu Liu, Lulu Xie, Yuying Zhang, et al.
Journal for Immunotherapy of Cancer|February 22, 2023
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinomaXiaobin Wang, Qiaoyun Zhang, Jingwen Zhou, et al.
Immunotargets and Therapy|November 3, 2025
Sorafenib Combined with Tislelizumab and Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Phase II StudyLicong Liang, Jingwen Zhou, Jingjun Huang, et al.
Advanced Healthcare Materials|October 17, 2023
Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma RecurrenceYe Chen, Jiaxin Bei, Meijuan Chen, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 22, 2024
Microbial-derived Urolithin A Targets GLS1 to Inhibit Glutaminolysis and Attenuate Cirrhotic Portal HypertensionRui Li, Zhile Liu, Wensou Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2020
Nanodrug with ROS and pH Dual-Sensitivity Ameliorates Liver Fibrosis via Multicellular RegulationLiteng Lin, Hengye Gong, Rui Li, et al.
BMC Cancer|January 21, 2025
3D synergistic tumor-liver analysis further improves the efficacy prediction in hepatocellular carcinoma: a multi-center studyYurong Jiang, Jiawei Zhang, Zhaochen Liu, et al.
Pageof 5